Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Double-Masked, Vehicle-Controlled, Evaluation of the Safety of CSF-1 in Presbyopic Subjects

NCT05393895 is registered in ClinicalTrials.gov with Orasis Pharmaceuticals Ltd. as lead sponsor.

NCT NCT05393895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05393895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Double-Masked, Vehicle-Controlled, Evaluation of the Safety of CSF-1 in Presbyopic Subjects
Lead sponsor
Orasis Pharmaceuticals Ltd.
Phase
Phase 3
Overall status
Completed
Start date
April 22, 2022
Completion date
December 1, 2022
Enrollment
178 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

presbyopia